Female Stress Urinary Incontinence Treatment Devices Market
Market Survey on Female Stress Urinary Incontinence Treatment Devices Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Female Stress Urinary Incontinence Treatment Devices Market including Sling Systems, Pessaries, Artificial Urinary Sphincters (AUS), and Injectable Urethral Bulking Agents Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Female Stress Urinary Incontinence Treatment Devices Market Outlook (2022 to 2029)
[195 Pages Report] Currently, the global female stress urinary incontinence treatment devices market is valued at US$ 702.4 Million and is expected to expand at a high CAGR of 6.2% (2022 to 2029) to end up with a market of US$ 1.07 Billion by the end of 2029.
Female Stress Urinary Incontinence Treatment Devices Market Size (2022) |
US$ 702.4 Million |
Projected Market Value (2029) |
US$ 1.07 Billion |
Forecast Growth Statistics (2022 to 2029) |
6.2% CAGR |
Dominant End-Use Segment |
Hospitals - 68.2% |
Female stress urinary incontinence treatment device sales accounted for a share of 20.5% in the global urinary incontinence treatment devices market in 2021. Going forward, female stress urinary incontinence treatment device shipments are expected to see an increase as awareness about the condition spreads via government initiatives across the world.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars |
Details |
H1, 2021 |
6.60% |
H1, 2022 Projected |
6.19% |
H1, 2022 Outlook |
5.69% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) |
(-) 50 ↓ |
BPS Change – H1, 2022 (O) - H1, 2021 |
(-) 91 ↓ |
The market is subject to be influenced by several regulatory and device considerations, as per the industry and macroeconomic standards. The key developments in the market include the launch of intravaginal devices and radiofrequency treatment for the management of female stress urinary incontinence.
The comparative analysis and market growth rate of the global female stress urinary incontinence treatment devices market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 91 Basis Point Share (BPS).
The reduction in the BPS values is associated with the limitations of female stress urinary incontinence treatment devices in patients with the fibrotic urethra. The adoption of treatment measures is thus limited and presents poor procedural outcomes.
However, with the emergence of neuromodulation for electric stimulation of the nerves in the pelvic area, the market for female stress urinary incontinence treatment devices is expected to present traction in terms of sales growth over the forecasted years.
Consumption Analysis Of Female Stress Urinary Incontinence Treatment Systems (2014 To 2021) Vs Future Industry Metrics (2022 To 2029)
The world has seen an increase in instances of urinary incontinence and this trend is expected to be prevalent over the forecast period as well. Demand for female stress urinary incontinence treatment devices rose at a CAGR of 5.9% from 2014 to 2021 and the market held a net value of US$ 652.4 Million in 2021.
The increasing prevalence of gynecologic disorders, growing incidence of urinary incontinence due to menopause, rising risk in post-menopausal women, and increasing prevalence in pregnant women are some of the major factors that are propelling demand for female stress urinary incontinence treatment drugs.
Medical conditions such as Parkinson’s disease, multiple sclerosis, muscle damage, loss of storage capacity in the rectum, etc., are also anticipated to increase the risk of urinary incontinence among females, and subsequently boost the sales of female stress urinary incontinence treatment systems.
Sales of female stress urinary incontinence treatment devices are anticipated to expand at a CAGR of 6.2% from 2022 to 2029.
Which Factors Will Positively Boost Female Stress Urinary Incontinence Treatment Devices Market Growth?
“Increase in Number of Female Stress Urinary Incontinence Treatment Procedures”
Over the past few years, there has been an increase in the adoption of female stress urinary incontinence treatment devices owing to the rising prevalence of the disease across the world.
The number of procedures performed for female stress urinary incontinence is seeing an upward trend and is anticipated to be a major driver for female stress urinary incontinence treatment device demand through 2029.
“Rising Awareness about Female Stress Urinary Incontinence”
Stress urinary incontinence is the most common type of urinary incontinence among pregnant women and since this is a matter of public health, there has been a substantial increase in efforts to boost awareness about this condition and help treat it effectively.
Governments and non-profit health organizations are launching initiatives to boost awareness and this is expected to favor the demand for female stress urinary incontinence treatment products.
What Could Negatively Impact Market Growth?
“Low Pricing of Female Stress Urinary Incontinence Treatment Devices by New Market Entrants”
The female stress urinary incontinence treatment devices market is stacked with the presence of a wide variety of female stress urinary incontinence treatment products, and small players in the industry are trying to maximize their sales in this vast marketplace.
These female stress urinary incontinence treatment device manufacturers are offering their products at lower prices to boost sales and this is expected to have a constraining effect on the overall female stress urinary incontinence treatment devices marketplace. The demand for expensive products is expected to be substantially affected by the aforementioned trend.
How Will The Female Stress Urinary Incontinence Treatment Devices Industry Perform Across Regions?
“North America & Europe to Emerge as Highly Lucrative Markets”
Demand analysis for the female stress urinary incontinence treatment devices market across regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been assessed in this research survey.
The North American female stress urinary incontinence treatment devices market is projected to have a dominant outlook through 2029. The presence of key female stress urinary incontinence treatment device suppliers, well-established healthcare infrastructure, and high spending potential is expected to be prominent factors driving market growth in this region.
Europe's female stress urinary incontinence treatment devices industry is also predicted to offer highly lucrative opportunities for female stress urinary incontinence treatment device manufacturers and is expected to be influenced by similar factors that drive the market in North America.
Increasing awareness from government and non-profit health organization initiatives is expected to drive female stress urinary incontinence treatment devices market growth in regions of East Asia and South Asia.
Low spending potential and underdeveloped healthcare infrastructure are expected to restrain market potential in the MEA region. The female stress urinary incontinence treatment devices market in this region is expected to rise at the slowest pace of all regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Country-Wise Analysis
Will the USA Be a Lucrative Market for Female Stress Urinary Incontinence Treatment Equipment Manufacturers?
“Presence of Developed Healthcare Infrastructure to Favour Regional Market Growth”
The U.S. is known for its developed healthcare infrastructure and this is projected to favor female stress urinary incontinence treatment devices market potential in the nation through 2029.
The presence of key female stress urinary incontinence treatment equipment suppliers and high healthcare spending potential in the nation are expected to aid market growth through the forecast period.
What is the Outlook for Sales of Female Stress Urinary Incontinence Treatment Devices in India?
“Government Initiatives to Boost Awareness Regarding Female Stress Urinary Incontinence”
Focus on healthcare has bolstered in recent years in India and the government has taken steps to increase awareness about multiple health conditions and this also includes urinary incontinence.
Increasing awareness about female stress urinary incontinence, developing healthcare infrastructure, and increasing healthcare spending are major factors influencing the female stress urinary incontinence treatment devices market growth in the nation.
Category-Wise Analysis
Which End-Use Accounts for Major Market Share?
“Hospitals Dominate Demand for Female Stress Urinary Incontinence Treatment Devices”
In 2022, the hospital's segment holds a market share of 68.2% and leads the global female stress urinary incontinence treatment industry landscape. This segment is expected to hold this dominant outlook through 2029 followed by gynecologic clinics which account for a market share of 30.6% at present. Sales of female stress urinary incontinence treatment devices are expected to be majorly driven by the hospital segment.
The homecare settings segment accounts for a 1.2% market share at present but is expected to increase over the forecast period as the popularity of homecare increases across the world. Homecare settings are expected to see a rise in popularity majorly in the North America and Europe regions.
COVID-19 Crisis Survey
The female stress urinary incontinence treatment devices market saw a negative growth trend in 2020 due to the emergence of coronavirus infections. The healthcare sector across the world was focused on treating and managing coronavirus infections, and this led to ignorance for all other medical conditions.
With lockdown restrictions placed in multiple countries there was a drop in sales of female stress urinary incontinence treatment devices and restricted manufacturing activity also has a negative impact on consumption of female stress urinary incontinence treatment devices.
Shipments of female stress urinary incontinence treatment devices are projected to rise at a steady pace in the post-pandemic era as the world returns to normal.
Competitive Landscape
Female stress urinary incontinence treatment device manufacturers are investing in research and development to boost their sales and increase revenue potential and expand their market presence on a global level.
- In December 2021, Caldera Medical, a medical device company focused on women’s health, announced that it received FDA clearance for new products to treat female stress urinary incontinence treatment. The launch of Desara® TVez is an addition to the existing line of Desara® products.
Female Stress Urinary Incontinence Treatment Devices Industry Report Scope
Attribute |
Details |
Forecast Period |
2022 to 2029 |
Historical Data Available for |
2014 to 2021 |
Market Analysis |
US$ Million for Value, Volume for Units |
Key Regions Covered |
|
Key Counties Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing |
Available upon Request |
Key Segments Of Female Stress Urinary Incontinence Treatment Devices Industry Survey
Female Stress Urinary Incontinence Treatment Devices Market by Product Type:
- Sling Systems
- Mid-Urethral Slings
- Sub-Urethral Slings
- Pessaries
- Artificial Urinary Sphincters (AUS)
- Injectable Urethral Bulking Agents
Female Stress Urinary Incontinence Treatment Devices Market by End Use:
- Female Stress Urinary Incontinence Treatment Devices for Hospitals
- Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
- Female Stress Urinary Incontinence Treatment Devices for Homecare Settings
Female Stress Urinary Incontinence Treatment Devices Market by Region:
- North America Female Stress Urinary Incontinence Treatment Devices Market
- Latin America Female Stress Urinary Incontinence Treatment Devices Market
- Europe Female Stress Urinary Incontinence Treatment Devices Market
- East Asia Female Stress Urinary Incontinence Treatment Devices Market
- South Asia & Pacific Female Stress Urinary Incontinence Treatment Devices Market
- Middle East & Africa (MEA) Female Stress Urinary Incontinence Treatment Devices Market
Frequently Asked Questions
What valuation does the female stress urinary incontinence treatment devices market enjoy?
The global female stress urinary incontinence treatment devices market holds a net valuation of US$ 702.4 Million in 2022.
What is the female stress urinary incontinence treatment devices market expected to be worth by 2029?
By 2029, the female stress urinary incontinence treatment systems market is expected to reach US$ 1.07 Billion.
What market share is held by the hospitals segment at present?
The hospital segment holds a major market share of 68.2% in 2022.
Which key female stress urinary incontinence treatment companies are mentioned in this research report?
Boston Scientific Corporation, Johnson & Johnson Services Inc., BD, Coloplast A/S, CooperSurgical Inc., MEDGYN PRODUCTS Inc., Cousin Biotech, Caldera Medical, Betatech Medical, and FEG Textiltechnik mbHare are major manufacturers of female stress urinary incontinence treatment products.
At what CAGR is the female stress urinary incontinence treatment devices market predicted to expand over the forecast period?
The female stress urinary incontinence treatment industry is estimated to progress at a high CAGR of 6.2% from 2022 to 2029.
Table of Content
1. Executive Summary | Female Stress Urinary Incontinence Treatment Devices Market 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 4. Key Success Factors 5. Global Market - Pricing Analysis 6. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029 6.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021 6.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Market Background 7.1. Macro-Economic Factors 7.1.1. Global GDP Growth Outlook 7.1.2. Global Healthcare Expenditure Outlook 7.2. Forecast Factors - Relevance & Impact 7.3. Market Dynamics 7.3.1. Drivers 7.3.2. Restraints 7.3.3. Opportunity Analysis 8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Product Type, 2014 to 2021 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2022 to 2029 8.3.1. Sling System 8.3.1.1. Mid-Urethral Sling 8.3.1.2. Sub-Urethral Sling 8.3.2. Pessaries 8.3.3. Artificial Urinary Sphincter (AUS) 8.3.4. Injectable Urethral Bulking Agents 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End Use 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By End Use, 2014 to 2021 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End Use, 2022 to 2029 9.3.1. Hospitals 9.3.2. Gynaecological Clinics 9.3.3. Homecare Settings 9.4. Market Attractiveness Analysis By End Use 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021 10.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. South Asia 10.3.5. East Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 11.1. Introduction 11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 11.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 11.3.1. By Country 11.3.1.1. The USA 11.3.1.2. Canada 11.3.2. By Product Type 11.3.3. By End Use 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product Type 11.4.3. By End Use 11.5. Drivers and Restraints - Impact Analysis 12. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 12.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Rest of Latin America 12.3.2. By Product Type 12.3.3. By End Use 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product Type 12.4.3. By End Use 12.5. Drivers and Restraints - Impact Analysis 13. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 13.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Italy 13.3.1.3. France 13.3.1.4. The UK 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Russia 13.3.1.8. Rest of Europe 13.3.2. By Product Type 13.3.3. By End Use 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product Type 13.4.3. By End Use 13.5. Drivers and Restraints - Impact Analysis 14. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 14.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Product Type 14.3.3. By End Use 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product Type 14.4.3. By End Use 14.5. Drivers and Restraints - Impact Analysis 15. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 15.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.2. By Product Type 15.3.3. By End Use 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product Type 15.4.3. By End Use 15.5. Drivers and Restraints - Impact Analysis 16. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 16.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product Type 16.3.3. By End Use 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product Type 16.4.3. By End Use 16.5. Drivers and Restraints - Impact Analysis 17. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume Trend Analysis By Market Taxonomy, 2014 to 2021 17.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkey 17.3.1.3. Northern Africa 17.3.1.4. South Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Product Type 17.3.3. By End Use 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product Type 17.4.3. By End Use 17.5. Drivers and Restraints - Impact Analysis 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies (s) 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Deep Dive 19.2.1. Boston Scientific Corporation 19.2.1.1. Overview 19.2.1.2. Product Portfolio 19.2.1.3. Sales Footprint 19.2.1.4. Strategy Overview 19.2.2. Johnson & Johnson Services. Inc. 19.2.2.1. Overview 19.2.2.2. Product Portfolio 19.2.2.3. Sales Footprint 19.2.2.4. Strategy Overview 19.2.3. BD 19.2.3.1. Overview 19.2.3.2. Product Portfolio 19.2.3.3. Sales Footprint 19.2.3.4. Strategy Overview 19.2.4. Coloplast A/S 19.2.4.1. Overview 19.2.4.2. Product Portfolio 19.2.4.3. Sales Footprint 19.2.4.4. Strategy Overview 19.2.5. CooperSurgical, Inc. 19.2.5.1. Overview 19.2.5.2. Product Portfolio 19.2.5.3. Sales Footprint 19.2.5.4. Strategy Overview 19.2.6. MEDGYN PRODUCTS, INC. 19.2.6.1. Overview 19.2.6.2. Product Portfolio 19.2.6.3. Sales Footprint 19.2.6.4. Strategy Overview 19.2.7. Cousin Biotech 19.2.7.1. Overview 19.2.7.2. Product Portfolio 19.2.7.3. Sales Footprint 19.2.7.4. Strategy Overview 19.2.8. Caldera Medical 19.2.8.1. Overview 19.2.8.2. Product Portfolio 19.2.8.3. Sales Footprint 19.2.8.4. Strategy Overview 19.2.9. Betatech Medical 19.2.9.1. Overview 19.2.9.2. Product Portfolio 19.2.9.3. Sales Footprint 19.2.9.4. Strategy Overview 19.2.10. FEG Textiltechnik mbH 19.2.10.1. Overview 19.2.10.2. Product Portfolio 19.2.10.3. Sales Footprint 19.2.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Size (US$ Million) Forecast By Regions, 2014 to 2029 Table 02: Global Market Size (US$ Million) Forecast By Product Type, 2014 to 2029 Table 03: Global Market Size (US$ Million) Forecast By End Use, 2014 to 2029 Table 04: North America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 05: North America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 06: North America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 07: Latin America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 08: Latin America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 09: Latin America Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 10: Europe Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 11: Europe Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 12: Europe Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 13: South Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 14: South Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 15: South Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 16: East Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 17: East Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 18: East Asia Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 19: Oceania Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 20: Oceania Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 21: Oceania Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 22: MEA Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Countries Table 23: MEA Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 24: MEA Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 25: China Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 26: China Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 27: India Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 28: India Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use Table 29: Japan Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type Table 30: Japan Market Size Analysis (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End Use
List of Charts
Figure 01: Global Market Value Share 2022E, By Region Figure 02: Global Market Value Share, By Product Type Figure 03: Regional Average Pricing Analysis (US$) of Mid-urethral Slings (2021A) Figure 04: Regional Average Pricing Analysis (US$) of Sub-urethral Slings (2021A) Figure 05: Regional Average Pricing Analysis (US$) of Artificial Urinary Sphincter (2021A) Figure 06: Regional Average Pricing Analysis (US$) of Injectable Urethral Bulking Agents (2021A) Figure 07: Regional Average Pricing Analysis (US$) of Pessaries and Inserts (2021A) Figure 08: Global Market Value (US$ Million), 2014 to 2021 Figure 09: Global Kits Absolute $ Opportunity (US$ Million), 2022 to 2029 Figure 10: Global Market Value Analysis and Forecast, 2021 to 2029 (US$ Million), By Systems Figure 11: Global Market Share Analysis (%) By Regions, 2022 to 2029 Figure 12: Global Market Y-o-Y Growth (%) By Regions, 2022 to 2029 Figure 13: Global Market Attractiveness Analysis By Regions, 2022 to 2029 Figure 14: Global Market Share Analysis (%) By Product Type, 2022 to 2029 Figure 15: Global Market Y-o-Y Growth (%) By Product Type, 2022 to 2029 Figure 16: Global Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 17: Global Market Share Analysis (%) By End Use, 2022 to 2029 Figure 18: Global Market Y-o-Y Growth (%) By End Use, 2022 to 2029 Figure 19: Global Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 20: North America Market Size (US$ Million) Analysis, 2014 to 2021 Figure 21: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 22: North America Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 23: North America Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 24: North America Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 25: North America Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 26: North America Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 27: North America Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 28: North America Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 29: North America Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 30: North America Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 31: North America Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 32: North America Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 33: Latin America Market Size (US$ Million) Analysis, 2014 to 2021 Figure 34: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 35: Latin America Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 36: Latin America Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 37: Latin America Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 38: Latin America Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 39: Latin America Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 40: Latin America Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 41: Latin America Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 42: Latin America Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 43: Latin America Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 44: Latin America Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 45: Latin America Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 46: Europe Market Size (US$ Million) Analysis, 2014 to 2021 Figure 47: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 48: Europe Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 49: Europe Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 50: Europe Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 51: Europe Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 52: Europe Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 53: Europe Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 54: Europe Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 55: Europe Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 56: Europe Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 57: Europe Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 58: Europe Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 59: South Asia Market Size (US$ Million) Analysis, 2014 to 2021 Figure 60: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 61: South Asia Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 62: South Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 63: South Asia Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 64: South Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 65: South Asia Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 66: South Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 67: South Asia Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 68: South Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 69: South Asia Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 70: South Asia Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 71: South Asia Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 72: East Asia Market Size (US$ Million) Analysis, 2014 to 2021 Figure 73: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 74: East Asia Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 75: East Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 76: East Asia Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 77: East Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 78: East Asia Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 79: East Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 80: East Asia Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 81: East Asia Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 82: East Asia Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 83: East Asia Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 84: East Asia Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 85: Oceania Market Size (US$ Million) Analysis, 2014 to 2021 Figure 86: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 87: Oceania Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 88: Oceania Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 89: Oceania Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 90: Oceania Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 91: Oceania Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 92: Oceania Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 93: Oceania Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 94: Oceania Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 95: Oceania Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 96: Oceania Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 97: Oceania Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 98: MEA Market Size (US$ Million) Analysis, 2014 to 2021 Figure 99: MEA Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 100: MEA Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 101: MEA Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 102: MEA Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 103: MEA Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 104: MEA Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 105: MEA Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 106: MEA Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 107: MEA Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 108: MEA Market Attractiveness Analysis By Countries, 2022 to 2029 Figure 109: MEA Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 110: MEA Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 111: China Market Size (US$ Million) Analysis, 2014 to 2021 Figure 112: China Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 113: China Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 114: China Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 115: China Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 116: China Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 117: China Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 118: China Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 119: China Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 120: China Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 121: China Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 122: China Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 123: India Market Size (US$ Million) Analysis, 2014 to 2021 Figure 124: India Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 125: India Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 126: India Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 127: India Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 128: India Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 129: India Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 130: India Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 131: India Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 132: India Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 133: India Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 134: India Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 135: Japan Market Size (US$ Million) Analysis, 2014 to 2021 Figure 136: Japan Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029 Figure 137: Japan Market Size (US$ Million) Analysis, By Sling System, 2014 to 2021 Figure 138: Japan Market Value (US$ Million) & Y-o-Y Growth (%), By Sling System, 2022 to 2029 Figure 139: Japan Market Size (US$ Million) Analysis, By Pessaries, 2014 to 2021 Figure 140: Japan Market Value (US$ Million) & Y-o-Y Growth (%), By Pessaries, 2022 to 2029 Figure 141: Japan Market Size (US$ Million) Analysis, By Artificial Urinary Sphincter, 2014 to 2021 Figure 142: Japan Market Value (US$ Million) & Y-o-Y Growth (%), By Artificial Urinary Sphincter, 2022 to 2029 Figure 143: Japan Market Size (US$ Million) Analysis, By Injectable Urethral Bulking Agents, 2014 to 2021 Figure 144: Japan Market Value (US$ Million) & Y-o-Y Growth (%), By Injectable Urethral Bulking Agents, 2022 to 2029 Figure 145: Japan Market Attractiveness Analysis By Product Type, 2022 to 2029 Figure 146: Japan Market Attractiveness Analysis By End Use, 2022 to 2029 Figure 147: Global Company Market Share Analysis, 2021
Recommendations
Explore Healthcare Insights
View Reports